Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2028 of 5804
-
Medical cannabis under the microscope: 1,000 patients tracked for Real-World relief
Symptom relief Recruiting nowThis prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.
Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New imaging may spot leukemia hiding outside the bone marrow
Diagnosis Recruiting nowThis pilot phase I trial studies how well positron emission tomography (PET)/magnetic resonance imaging (MRI), fludeoxyglucose F-18 (18F-FDG) PET/computed tomography (CT), and whole body MRI work in finding extramedullary myeloid leukemia in patients with newly diagnosed acute my…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
New drug shows promise for relieving severe itch in liver disease
Symptom relief OngoingThis is an open-label, non-comparator, global, multi-center, long-term safety study for evaluating safety and tolerability of linerixibat in participants with cholestatic pruritus in primary biliary cholangitis (PBC) who participated in a prior clinical trial with linerixibat (BA…
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Plasma from recovered patients studied to unlock COVID-19 treatment secrets
Knowledge-focused OngoingPlasma from patients who have recovered from coronavirus disease 2019 (COVID-19) is referred to as COVID-19 convalescent plasma (CCP), and may contain antibodies against SARS-CoV-2, the virus responsible for COVID-19. CCP infusion is being evaluated as a therapeutic or prophylact…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New whooping cough vaccine shows promise for toddlers
Disease control CompletedRecombinant acellular pertussis vaccines containing genetically detoxified Pertussis Toxin (PTgen) have been used for booster immunisation in children, adolescents and adults including pregnant women in Thailand. Three vaccines have been licensed in Thailand, a monovalent (aPgen)…
Phase: PHASE2, PHASE3 • Sponsor: BioNet-Asia Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug targets genetic weakness in Hard-to-Treat cancers
Disease control OngoingThis is a single arm, open-label, lead in phase Ib dose confirmation, followed by phase II study with 2 parallel study cohorts. Patients will be pre-screened for presence of 1q21.3 copy number amplification in plasma samples prior to screening process. Only patients with confirme…
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a quick genetic test save critically ill newborns?
Diagnosis ENROLLING_BY_INVITATIONThe purpose of this study is to understand how the use of whole genome sequencing (WGS) may be able to increase the speed with which a diagnosis is made for patients in an intensive care unit population. This is not an assessment of a new device, test, or technology. This project…
Phase: NA • Sponsor: Jerry Vockley, MD, PhD • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Can combo drugs penetrate tough brain tumors? new study seeks answers
Knowledge-focused CompletedThis trial is an open-label, multicenter, Phase 0/2 trial that will enroll up to 50 participants with recurrent glioblastoma which are schedule for resection. In the lead-in cohort, a total of 10 participants will be enrolled into the proposed phase 0 clinical trial. Participants…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New drug duo aims to reboot immune attack on Hard-to-Treat cancers
Disease control CompletedThe main purpose of this study was to determine the safety, tolerability, pharmacokinetics (PK), immunogenicity and (if observed) the maximum tolerated dose (MTD) of M6223 as a single agent (Part 1A) for both the every 2 weeks (Q2W) regimen and the every 3 weeks (Q3W) regimen and…
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Genetic testing aims to tackle kidney disease racial gap
Knowledge-focused CompletedGUARDD-US is a prospective, multicenter, unblinded, two arm randomized pragmatic clinical trial. Participants will be randomized in a 1:1 ratio to immediate APOL1 gene testing and return of results (ROR) to participant and provider (Intervention arm) versus delayed APOL1 gene tes…
Phase: NA • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Fingerprick COVID-19 antibody test put to the test
Diagnosis CompletedEvaluation of the agreement between fingerstick samples, venous blood, serum and plasma samples when using the LumiraDx SARS-CoV-2 Ab Test against the reference method, using standard qualitative comparison techniques.
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
BESPONSA under the microscope: korean study tracks Real-World safety
Disease control CompletedBesponsa is approved for the treatment of R/R B-cell ALL in Korea. In accordance with the Standards for Re-examination of New Drug, it is required to conduct a PMS. Post marketing surveillance is required to determine any problems or questions associated with besponsa after marke…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New study aims to catch eye cancer spread early with blood tests and scans
Knowledge-focused Recruiting nowBiomarkers search for early diagnosis of liver metastases in patients with uveal melanoma who benefit from a follow-up tailored to their personalized risk of relapse.
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:18 UTC
-
Magnetic ring for heartburn tracked for 10 years
Disease control OngoingThe RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and…
Sponsor: Ethicon Endo-Surgery • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Shorter radiation after hysterectomy shows promise for endometrial cancer
Disease control CompletedThe goal of this study is to evaluate short course radiation in the post-operative female pelvis after hysterectomy in stage III-IVA endometrial adenocarcinoma patients, or any stage patients with uterine serous or carcinosarcoma histology. The investigators hypothesize that shor…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can better hospital discharge planning keep seniors out of the ER?
Disease control OngoingThe study is a randomized controlled trial to estimate the effects of the transitional care model (TCM) on hospital admissions and patients' experience during the year following the patient's qualifying discharge. The University of Pennsylvania, where TCM was developed, will be t…
Phase: NA • Sponsor: Mathematica Policy Research, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New stent aims to unclog dialysis veins
Disease control CompletedThe objective of this study is to collect post-market, real-world safety and effectiveness data of the COVERA Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the arteriovenous (AV) access circuit.
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
700 breast cancer patients join study to track how CDK4/6 drugs work in real life
Knowledge-focused Recruiting nowThis study investigates the clinical course of CDK4/6 inhibitor treated patients in the real-world setting among patients with breast cancer. CDK4/6 inhibitors may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Studying samples of blood, ti…
Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Cast length showdown: does a shorter cast speed wrist fracture recovery?
Disease control CompletedThe goal of this clinical trial was to compare two casting strategies for adults with a broken wrist, also called a distal radius fracture. The study included people whose treating team had determined that treatment without surgery was appropriate. Their fracture was first put ba…
Phase: NA • Sponsor: Istanbul University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can aggressive meds shrink hidden plaque in women's arteries?
Knowledge-focused CompletedIn this study, quantitative characterization of plaque using coronary computed tomographic angiography (CTA) will be used to determine if women who were treated with intensive medical therapy have a greater reduction in the amount and type of cholesterol plaque compared to women …
Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC